Published June 30, 2025
| Version v1
Journal article
Open
Impact of clinical pharmacist-led interventions on glycemic control and quality of life among Iraqi patients with type 1 diabetes mellitus
Authors/Creators
- 1. Baghdad Al-Karkh Health Directorate, Iraqi Ministry of Health, Baghdad, Iraq
- 2. University of Baghdad, Baghdad, Iraq
- 3. Baghdad Al-Russafa Health Directorate, Iraqi Ministry of Health, Baghdad, Iraq
Description
Adequate glycemic management reduces complications related to diabetes and enhances the patient's quality of life. This study intended to evaluate pharmacist-led educational initiatives on glycemic management and quality of life (QOL) in individuals with type 1 diabetes. Pharmacists have a significant effect on the treatment of people with diabetes mellitus (DM) and a vital role in the enhancement of QOL. The objective of the study is to assess the efficacy of pharmacist-led intervention (PI) on the glycemic control and QOL of adult patients with type 1 DM in Iraq. The current study is a prospective, comparative, pre-post intervention study on patients with type 1 DM who attended a Specialized Center for Endocrinology and Diabetes in Baghdad, Al-Russafa. At baseline, the glycated hemoglobin (HbA1C) and fasting blood glucose (FBS) were recorded, and the QOL was assessed by filling out the Quality-of-Life Scale for Iraqi Diabetes Mellitus Patients (QOLSID) questionnaire for each patient in both cohorts. After that, the patients in the interventional group received a face-to-face educational session, which lasted about 20–30 minutes. Then, an Arabic educational booklet was handed out to each patient in the interventional group. Three months later, the same parameters were re-measured for the same patients in both study groups. The percentage of patients demonstrating glycemic control was significantly higher than that of the control group (36.4% vs. 2.3%). The QOL score significantly increased in the intervention group (10.0% vs. 3.0%) compared to the control group. Our study concludes that a clinical pharmacist-led educational intervention may improve the glycemic control and QOL of type 1 DM.
Files
PHAR_article_156398.pdf
Files
(1.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:2bacacfd5a07562454760040fc960da2
|
937.3 kB | Preview Download |
|
md5:8042bba2ca837fc0df78dbde575ad9ab
|
95.4 kB | Preview Download |
Additional details
References
- Abbas JK, Al-metwali BZ (2023) The impact of pharmacist behavioral intervention on antibiotics prescribing in pediatric wards. F1000Research 12: 458. https://doi.org/10.12688/f1000research.132579.1
- Abbood SK, Assad HC, Al-Jumaili AA (2019) Pharmacist intervention to enhance postoperative fluid prescribing practice in an Iraqi hospital through implementation of NICE guideline. Pharmacy Practice 17(3): 1552. https://doi.org/10.18549/pharmpract.2019.3.1552
- Abusaib M, Ahmed M, Nwayyir HA, Alidrisi HA, Al-Abbood M, Al-bayati A, AL-Ibrahimi S, AL-Kharasani A, AL-Rubaye H, Mahwi T (2020) Iraqi experts consensus on the management of type 2 diabetes/prediabetes in adults. Clinical Medicine Insights: Endocrinology and Diabetes 13: 1179551420942232. https://doi.org/10.1177/1179551420942232
- Adibe MO, Ukwe CV, Aguwa CN (2013) The impact of pharmaceutical care intervention on the quality of life of Nigerian patients receiving treatment for type 2 diabetes. Value in health regional issues 2: 240–247. https://doi.org/10.1016/j.vhri.2013.06.007
- AL-Banna K, Khuder SA (2015) effectiveness of the education program on diabetic patients' knowledge and practice regarding self-administration of insulin in Erbil City. Kufa J Nurs Sci 5: 33–42. https://doi.org/10.36321/kjns.vi20153.2780
- AL-Musawi M, Anwer ZM (2021) Evaluating the impact of pharmacist counselling for asthmatic children at Karbala Teaching Hospital for Children: An interventional prospective study (Conference paper). Iraqi Journal of Pharmaceutical Sciences 30: 22–30. https://doi.org/10.31351/vol30isssuppl.pp22-30
- Albai O, Braha A, Timar B, Timar R (2024) Predictive factors for altered quality of life in patients with type 2 diabetes mellitus. Journal of Clinical Medicine 13(15): 4389. https://doi.org/10.3390/jcm13154389
- Ali MM, AL-Jumaili AA (2023) Appraising the role of pharmacists in medication reconciliation at hospital discharge: A field-based study. Al-Rafidain Journal of Medical Sciences 5: S57–63. https://doi.org/10.54133/ajms.v5i1s.319
- Alkashaf KH, Mohammed SI (2024) Impact of clinical pharmacist intervention on chemotherapy knowledge, attitude, and practice among breast cancer women. Journal of the Faculty of Medicine Baghdad 66: 103–109. https://doi.org/10.32007/jfacmedbagdad.661222
- Butt M, Mhd Ali A, Bakry MM, Mustafa N (2016) Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled study. Saudi Pharmaceutical Journal 24(1): 40–48. https://doi.org/10.1016/j.jsps.2015.02.023
- Cando LFT, Quebral EPB, Ong EP, Catral CDM, Relador RJL, Velasco AJD, Alcazar RMU, Reyes NAL, Pilotin EJB, Ornos EDB, Paz-Pacheco E, Tantengco OAG (2024) Current status of diabetes mellitus care and management in the Philippines. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 18(2): 102951. https://doi.org/10.1016/j.dsx.2024.102951
- Chen J, Yin D, Dou K (2023) Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions. Cardiovascular Diabetology 22(1): 146. https://doi.org/10.1186/s12933-023-01875-8
- Chua SS, Chung WW, Lai PSM, Chan SP (2014) Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Preference and Adherence 8: 1185–1194. https://doi.org/10.2147/ppa.s66619
- Du M, Li S, Jiang J, Ma X, Liu L, Wang T, Zhang J, Niu D (2025) Advances in the pathogenesis and treatment strategies for type 1 diabetes mellitus. International Immunopharmacology 148: 114185. https://doi.org/10.1016/j.intimp.2025.114185
- ElSayed N. A, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA (2022) 6. Glycemic Targets: Standards of Care in Diabetes—2023. Diabetes Care 46(Supplement_1): S97–S110. https://doi.org/10.2337/dc23-s006
- Falah MJ, Jasim AL (2023) The Impact of Implementing a Pharmacist-led Deprescribing Program on Medication Adherence among Hemodialysis Patients. Al-Rafidain Journal of Medical Sciences 5(1S): 29–36. https://doi.org/10.54133/ajms.v5i1s.290
- Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M (2011) Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 16(1): 43–49.
- Ferreira PL, Morais C, Pimenta R, Ribeiro I, Amorim I, Alves SM, Santiago L (2024) Knowledge about type 2 diabetes: its impact for future management. Frontiers in Public Health 12: 1328001. https://doi.org/10.3389/fpubh.2024.1328001
- Guan H, Tian J, Wang Y, Niu P, Zhang Y, Zhang Y, Fang X, Miao R, Yin R, Tong X (2024) Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review. European Journal of Medical Research 29(1): 152 . https://doi.org/10.1186/s40001-024-01739-1
- Herold CK, Gitelman ES, Gottlieb AP, Knecht AL, Raymond R, Ramos LE (2023) Teplizumab: A disease-modifying therapy for type 1 diabetes that preserves β-cell function. Diabetes Care 46(10): 1848–1856. https://doi.org/10.2337/dc23-0675
- Hill J, Nielsen M, Fox MH (2013) Understanding the social factors that contribute to diabetes: A means to informing health care and social policies for the chronically ill. The Permanente Journal 17(2): 67–72. https://doi.org/10.7812/tpp/12-099
- Hussain A, Bowen AM (2024) Exploring pharmacist roles in telepharmacy for chronic disease management in New York State: A qualitative inquiry into improving implementation, patient communication, and healthcare technology support. Cureus 16(6): e62982. https://doi.org/10.7759/cureus.62982
- Jabri AM, Assad HCh, Al-Jumaili AA (2020) Pharmacist role to enhance the prescribing of hospital discharge medications for patients after heart attack. Saudi Pharmaceutical Journal 28(4): 473–479. https://doi.org/10.1016/j.jsps.2020.02.009
- Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, Ashouri A, Radfar M, Javadi M, Gholami K (2014) Effect of a community pharmacist–delivered diabetes support program for patients receiving specialty medical care. The Diabetes Educator 41(1): 127–135. https://doi.org/10.1177/0145721714559132
- Jabbar RK, Jammal YM (2023) Factors associated with Adherence to Insulin Self-Administration among Children and Adolescents with Type 1 DM in Iraq. Iraqi Journal of Pharmaceutical Sciences 32(Suppl.): 291–299. https://doi.org/10.31351/vol32isssuppl.pp291-299
- Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T (2012) Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. Journal of Managed Care Pharmacy 18(7): 516–526. https://doi.org/10.18553/jmcp.2012.18.7.516
- Janež A, Guja C, Mitrakou A, Lalic N, Tankova T, Czupryniak L, Tabák AG, Prazny M, Martinka E, Smircic-Duvnjak L (2020) Insulin therapy in adults with type 1 diabetes mellitus: a narrative review. Diabetes Ther 11(2): 387–409. https://doi.org/10.1007/s13300-019-00743-7
- Khazal AA, Jamal MY (2023) Pharmacist intervention to address drug related problems in patients with decompensated liver cirrhosis. AL-Kindy College Medical Journal 19(1): 121–126. https://doi.org/10.47723/kcmj.v19i1.888
- Kovil R, Chawla M, Rajput R, Singh AK, Sinha B, Ghosal S, Ballani P, Gupta S, Tanna S, Bandukwala SM (2017) Consensus on insulin dose and titration algorithms in ambulatory care of type 2 diabetes in India. The Journal of the Association of Physicians of India 65: 17–30.
- Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinso J (2007) The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine 24: 677–683. https://doi.org/10.1111/j.1464-5491.2007.02143.x
- Longendyke R, Grundman JB, Majidi S (2024) Acute and chronic adverse outcomes of type 1 diabetes. Endocrinol Metab Clin North Am 53(1): 123–133. https://doi.org/10.1016/j.ecl.2023.09.004
- Megari K (2013) Quality of life in chronic disease patients. Health Psychology Research 1(3): 27. https://doi.org/10.4081/hpr.2013.e27
- Mikhael EM, Hassali MA, Hussain SA (2020a) Effectiveness of diabetes self-management educational programs for type 2 diabetes mellitus patients in Middle East countries: a systematic review. Diabetes, Metabolic Syndrome and Obesity 13: 117–138. https://doi.org/10.2147/DMSO.S232958
- Mikhael EM, Hassali MA, Hussain SA, Mustafa MY (2018) Assessment of pharmacist's role in counselling and educating diabetic patients about insulin therapy. Int Res J Pharm 9(7): 65–68. https://doi.org/10.7897/2230-8407.097127
- Mikhael EM, Hassali MA, Hussain SA, Shawky N (2020b) The development and validation of quality of life scale for Iraqi patients with type 2 diabetes mellitus. Journal of Pharmacy and Bioallied Sciences 12: 262–268. https://doi.org/10.4103/jpbs.jpbs_190_19
- Mikhael EM, Hassali MA, Hussain SA, Shawky N, Hassali MA (2019) Validity and reliability of anti-diabetic medication adherence scale among patients with diabetes in Baghdad, Iraq: a pilot study. BMJ Open Diabetes Research and Care 7: e000658. https://doi.org/10.1136/bmjdrc-2019-000658
- Norris JM, Johnson RK, Stene LC (2020) Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol 8(3): 226–238. https://doi.org/10.1016/s2213-8587(19)30412-7
- Raheem MF, Ali SH, Shareef LG (2022) Impact of serum levels of vitamin D on lipid profiles, glycemic indices, and insulin resistance in obese type 2 diabetes patients: An observational study. F1000Research 11: 1002. https://doi.org/10.12688/f1000research.125191.1
- Shehab FA, Jasim AL, Mohammed AG (2024) Impact of gliclazide modified release or glimepiride as add-on therapy to metformin on glycemic and oxidative stress parameters in type 2 diabetic patients. Iraqi Journal of Pharmaceutical Sciences 33: 20–30. https://doi.org/10.31351/vol33iss2pp20-30
- Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK (2016) Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker insights 11: 95–104. https://doi.org/10.4137/bmi.s38440
- Sriram S, Chack LE, Ramasamy R, Ghasemi A, Ravi TK, Sabzghabaee AM (2011) Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 16: S412–S418.
- Suprapti B, Izzah Z, Yoshida MA, Puspitasari AD, Nugroho CW (2022) Impact of pharmacist-led education on knowledge, adherence, and glycaemic control of type 2 diabetic outpatients. Pharmacy Education 22: 795–804. https://doi.org/10.46542/pe.2022.221.795804
- Tan JK, Lim GH, Mohamed NN, Chia SY, Thumboo J, Bee YM (2023) Associations between mean HbA1c, HbA1c variability, and both mortality and macrovascular complications in patients with diabetes mellitus: a registry-based cohort study. Clinical Epidemiology 15: 137–149. https://doi.org/10.2147/clep.s391749